(Q57255770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Christine Blasey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Keith Sudheimer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jaspreet Pannu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Heather Pankow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jessica Hawkins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Justin Birnbaum

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Nolan R Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

David M Lyons

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Carolyn I Rodriguez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Alan F Schatzberg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

29 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Psychiatry

20 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

1205-1215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

Comparative pharmacology of the optical isomers of ketamine in mice

20 April 2020

cites work

1 reference

12 December 2020

The development of tolerance to ketamine in rats and the significance of hepatic metabolism

1 reference

12 December 2020

The development of an acute tolerance to ketamine

1 reference

12 December 2020

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

12 December 2020

Asymmetrical distribution of beta-endorphin in cerebral hemispheres of suicides: preliminary data

1 reference

12 December 2020

Regionally selective increases in mu opioid receptor density in the brains of suicide victims

1 reference

12 December 2020

Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation.

1 reference

12 December 2020

Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro

1 reference

12 December 2020

Buprenorphine has potent kappa opioid receptor antagonist activity

1 reference

12 December 2020

Duration of occupancy of opiate receptors by naltrexone

1 reference

12 December 2020

Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice

1 reference

12 December 2020

Current and historical concepts of opiate treatment in psychiatric disorders.

1 reference

12 December 2020

Opiate modulation of separation-induced distress in non-human primates

1 reference

12 December 2020

[A case of ketamine dependence]

1 reference

12 December 2020

Naltrexone and dysphoria: a double-blind placebo controlled trial

1 reference

12 December 2020

Opiate Receptor Mediation of Ketamine Analgesia

1 reference

12 December 2020

Opioid agonist and antagonist behavioural effects of buprenorphine

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

Tolerance to rectal ketamine in paediatric anaesthesia

1 reference

12 December 2020

1 reference

12 December 2020

Development of tolerance to ketamine in an infant undergoing repeated anesthesia.

1 reference

12 December 2020

Increased density of mu-opioid receptors in the postmortem brain of suicide victims

1 reference

12 December 2020

Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception

1 reference

12 December 2020

Buprenorphine treatment of refractory depression

1 reference

12 December 2020

Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors

1 reference

12 December 2020

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

12 December 2020

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

12 December 2020

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

12 December 2020

Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

1 reference

12 December 2020

Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons.

1 reference

12 December 2020

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

12 December 2020

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

12 December 2020

The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception

1 reference

12 December 2020

Naltrexone and dysphoria: fact or myth?

1 reference

12 December 2020

Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain

1 reference

12 December 2020

Ketamine as a preferred substance of abuse

1 reference

12 December 2020

Ketamine associated psychedelic effects and dependence

1 reference

12 December 2020

Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans

1 reference

12 December 2020

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder

1 reference

12 December 2020

Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism

1 reference

12 December 2020

Recent trends in drug abuse in China

1 reference

12 December 2020

A case of ketamine dependence with discontinuation symptoms.

1 reference

12 December 2020

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

12 December 2020

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

12 December 2020

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects

1 reference

12 December 2020

Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

1 reference

12 December 2020

Kappa-opioid ligands in the study and treatment of mood disorders

1 reference

12 December 2020

RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).

1 reference

12 December 2020

Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases

1 reference

12 December 2020

A case of ketamine dependence

1 reference

12 December 2020

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence

1 reference

12 December 2020

Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys

1 reference

12 December 2020

Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

1 reference

12 December 2020

Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens

1 reference

12 December 2020

Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study

1 reference

12 December 2020

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

1 reference

12 December 2020

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum

1 reference

12 December 2020

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

1 reference

12 December 2020

The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

1 reference

12 December 2020

The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms

1 reference

12 December 2020

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

1 reference

12 December 2020

1 reference

12 December 2020

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine

1 reference

12 December 2020

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

1 reference

12 December 2020

Opioid receptors: distinct roles in mood disorders

1 reference

12 December 2020

Ketamine for chronic pain: risks and benefits

1 reference

12 December 2020

The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies

1 reference

12 December 2020

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept

1 reference

12 December 2020

The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use

1 reference

12 December 2020

Therapeutic infusions of ketamine: do the psychoactive effects matter?

1 reference

12 December 2020

A word to the wise about ketamine

1 reference

12 December 2020

Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.

1 reference

12 December 2020

Do the dissociative side effects of ketamine mediate its antidepressant effects?

1 reference

12 December 2020

It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system

1 reference

12 December 2020

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

1 reference

12 December 2020

Interventional psychiatry: why now?

1 reference

12 December 2020

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults

1 reference

12 December 2020

Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation.

1 reference

12 December 2020

A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression

1 reference

12 December 2020

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

1 reference

12 December 2020

Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor

1 reference

12 December 2020

Development of a checklist of short-term and long-term psychological symptoms associated with ketamine use.

1 reference

12 December 2020

Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction

1 reference

12 December 2020

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

1 reference

12 December 2020

Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial

1 reference

12 December 2020

NMDA antagonist treatment of depression

1 reference

12 December 2020

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial

1 reference

12 December 2020

Kappa Opioids, Salvinorin A and Major Depressive Disorder

1 reference

12 December 2020

Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment

1 reference

12 December 2020

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

1 reference

12 December 2020

Increase in Suicide in the United States, 1999-2014.

1 reference

12 December 2020

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

1 reference

12 December 2020

A REVIEW OF KETAMINE ABUSE AND DIVERSION.

1 reference

12 December 2020

The influence of prescription opioid use duration and dose on development of treatment resistant depression

1 reference

12 December 2020

Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trial

1 reference

12 December 2020

The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.

1 reference

12 December 2020

The practicalities and ethics of ketamine for depression

1 reference

12 December 2020

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.

1 reference

12 December 2020

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.

1 reference

12 December 2020

Depression Is the Leading Cause of Disability Around the World

1 reference

12 December 2020

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study

1 reference

12 December 2020

A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6).

1 reference

12 December 2020

New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.

1 reference

12 December 2020

The Role of Science in Addressing the Opioid Crisis

1 reference

12 December 2020

Effects of a ketamine metabolite on synaptic NMDAR function.

1 reference

12 December 2020

Prescription Opioid Use among Adults with Mental Health Disorders in the United States

1 reference

12 December 2020

Side-effects associated with ketamine use in depression: a systematic review.

1 reference

12 December 2020

Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit

1 reference

12 December 2020

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling

1 reference

12 December 2020

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

1 reference

12 December 2020

10.1176/APPI.AJP.2018.18020138

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30153752%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

PubMed publication ID

30153752

1 reference